MedTrace Logo

Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC)

NCT03648632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-04-20

No results posted yet for this study

Summary

Stereotactic Radiotherapy (SBRT) in patients with locally advanced pancreatic cancer (LAPC).

A Danish phase II study.

Conditions

Interventions

RADIATION

Stereotactic Radiotherapy

Patients should be treated with 50 Gy in 5 fractions within a total of 7 - 8 days.

Sponsors & Collaborators

  • Per Pfeiffer

    lead OTHER

Principal Investigators

  • Per Pfeiffer, Professor · Odense Universitetshospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-22
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648632 on ClinicalTrials.gov